Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.40M | 25.86M | 20.91M | 12.16M | 18.21M |
| Total Depreciation and Amortization | 13.97M | 15.95M | 14.93M | 12.69M | 8.06M |
| Total Amortization of Deferred Charges | 1.53M | -- | -- | 1.55M | 6.58M |
| Total Other Non-Cash Items | -8.90M | 304.00K | 2.35M | 640.00K | 4.46M |
| Change in Net Operating Assets | 19.39M | 4.11M | -15.99M | -13.23M | 4.65M |
| Cash from Operations | 50.39M | 46.22M | 22.20M | 13.81M | 41.95M |
| Capital Expenditure | -5.85M | -7.88M | -10.22M | -3.69M | 4.19M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -7.16M | -3.28M | -1.02M | -3.24M | 8.28M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.05M | -902.00K | 3.88M | -4.71M | -7.69M |
| Cash from Investing | -15.06M | -12.06M | -7.36M | -11.64M | 4.79M |
| Total Debt Issued | 0.00 | -- | 57.76M | 8.71M | -21.68M |
| Total Debt Repaid | -32.46M | -18.03M | -69.38M | -6.46M | -6.33M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.80M | -2.67M | -3.00M | -1.28M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | -5.16M | -1.00K | -- | -9.65M |
| Cash from Financing | -35.26M | -25.86M | -14.63M | 969.00K | -37.66M |
| Foreign Exchange rate Adjustments | 368.00K | -343.00K | 2.14M | 2.47M | -4.13M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -2.00K |
| Net Change in Cash | 433.00K | 7.96M | 2.35M | 5.61M | 4.96M |